U.S. Renal Care — Arlington, Texas

U.S. Renal Care is a clinical research site located in Arlington, Texas, United States 76011.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

U.S. Renal Care has participated in 1 clinical trials.

Therapeutic areas: Chronic Kidney Failure.

Sponsors: Ineos Healthcare Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Arlington

Browse all research sites in Texas · View every site in Arlington

• Millwood Hospital
• The University of Texas at Arlington
• University of Texas at Arlington Movement & Physical Activity Epidemiology Laboratory
• University of Texas Arlington
• Texas Health Heart and Vascular Hospital
• University of Texas at Arlington
• Texas Health Arlington Memorial Hospital
• Engineering Research Building (ERB), University of Texas Arlington
• Presbyterian Hospital Dallas
• USMD Hospital
• Arlington Research Center
• Texas Clinical Research Institute

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for U.S. Renal Care?

U.S. Renal Care has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has U.S. Renal Care conducted?

U.S. Renal Care has 1 clinical trials on record. Their work covers Chronic Kidney Failure.

Is U.S. Renal Care accredited by Crixeo Clinical Trials?

U.S. Renal Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about U.S. Renal Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.